Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: Data from an Italian multicenter study

Journal of Chemotherapy

Volumn 19, Issue 5, 2007, Pages 500-507

  Mazzariol, A ^a   Koncan, R ^a   Bahar, G ^b   Cornaglia, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Department of Anesthesiology   (Turkey)

Author keywords

Azithromycin; Clarithromycin; Erythromycin; Macrolides; Penicillin; Resistance to macrolides; Streptococcus pneumoniae; Streptococcus pyogenes; Telithromycin

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; KETOLIDE; MACROLIDE; PENICILLIN G; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; INCIDENCE; ITALY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 36549090490     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.5.500     Document Type: Article

References (20)

1. Kaplan EL, Cornaglia G. Persistent macrolide resistance among group A streptococci: the lack of accomplishment after 4 decades. Clin Infect Dis 2005; 41: 609-611.
2. Cornaglia G. Macrolide resistance and Streptococcus pyogenes: molecular basis, epidemiology and clinical significance. Rev Med Microbiol 1999; 10: 1-14.
3. Cornaglia G, Bryskier A. Macrolides resistance of Streptococcus pyogenes. In J.C. Pechère and E.L. Kaplan (eds.), Optimal management of streptococcal pharyngitis: epidemiology, diagnosis, treatment and public health considerations. Karger AG, Basel, 2003:150-165.
4. Cornaglia G, Ligozzi M, Mazzariol A, et al. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg Inf Dis 1996; 2: 339-342.
5. Marchese A, Tonoli E, Debbia EA, Schito GC. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother 1999; 44: 461-464.
6. Cornaglia G, Lo Cascio G, Masala L, et al. Macrolide resistance among Streptococcus pneumoniae isolates in Italy. In: S.H. Zinner, L.S. Young, F. Acar and C. Ortiz-Neu (eds.), New Considerations for Macrolides, Azalides, Streptogramins, and Ketolides. Marcel Dekker, Inc., New York, 1999: 250-254.
7. Marchese A, Gualco L, Cochetti I, et al. Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents 2005; 26: 138-145.
8. Reinert RR, Reinert S, van der Linden M, et al. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 2903-2913.
9. Kataja, J, Huovinen P, Skurnik M, et al. Erythromycin resistance in Group A streptococci in Finland. Antimicrob Agents Chemother 1999; 43: 48-52.
10. Maruyama S, Yoshioka H, Fujita K, et al. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child 1979; 133: 1143-1145.
11. Bassetti M, Mantero E, Gatti G, et al. Streptococcus pyogenes erythromycin resistance in Italy. Emerg Infect Dis 1999; 5; 302-303.
12. Perez-Trallero E, Marimon JM, Montes M, et al. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg Infect Dis 1999; 5: 235-240.
13. Bemel-Melchior P, Juvin ME, Tassin S, et al. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob Agents Chemother 2000; 44: 2999-3002.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. CLSI document M100-S16. 2005. Clinical and Laboratory Standards Institute. Villanova, Pa.
15. Seppälä H, Nissinen A, Yu Q, Huovinen P. Three different phenotypes of erythromycin-resistant S. pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885-891.
16. Daly MM, Doktor S, Flamm R, Shortridge D. Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates. J Clin Microbiol 2004; 42: 3570-3574.
17. Marchese A, Ardito F, Fadda G, et al. PROTEKT ITALY 2004: analysis of the results obtained from bacterial pathogens causing respiratory infections in paediatric patients. GIMMOC 2006; 10:67-101.
18. Al-Lahham A, Appelbaum PC, van der Linden M, Reinert RR. Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe. Antimicrob Agents Chemother. 2006; 50: 3897-3900.
19. Cantón R, Mazzariol A, Morosini M-I, et al. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J Antimicrob Chemother 2005; 55: 489-495.
20. th European Congress of Clinical Microbiology and Infectious Diseases. Nice, France, April 1-4, 2006. Abstract P1591.